Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Lynne, Uhl"'
Autor:
Kerry L. O'Brien, Scott A. Shainker, Jeannie Callum, Ramen H. Chmait, Noor Niyar N. Ladhani, Yulia Lin, Susan D. Roseff, Alireza A. Shamshirsaz, Lynne Uhl, Richard L. Haspel
Publikováno v:
Transfusion. 63:249-256
Autor:
Edward L. Snyder, Allison P. Wheeler, Majed Refaai, Claudia S. Cohn, Jessica Poisson, Magali Fontaine, Mary Sehl, Ajay K. Nooka, Lynne Uhl, Philip Spinella, Maly Fenelus, Darla Liles, Thomas Coyle, Joanne Becker, Michael Jeng, Eric A. Gehrie, Bryan R. Spencer, Pampee Young, Andrew Johnson, Jennifer J. O'Brien, Gary J. Schiller, John D. Roback, Elizabeth Malynn, Ronald Jackups, Scott T. Avecilla, Jin‐Sying Lin, Kathy Liu, Stanley Bentow, Ho‐Lan Peng, Jeanne Varrone, Richard J. Benjamin, Laurence M. Corash
Publikováno v:
Transfusion, vol 62, iss 7
BackgroundPlatelet transfusion carries risk of transfusion-transmitted infection (TTI). Pathogen reduction of platelet components (PRPC) is designed to reduce TTI. Pulmonary adverse events (AEs), including transfusion-related acute lung injury and ac
Autor:
David Avigan, Donald Kufe, Kenneth Anderson, Jacob Rowe, Viki Held, Lina Bisharat, Yan Emily Yuan, Vassiliki Boussiotis, Noopur Raje, Jacob Laubach, Paul Richardson, Dimitrios Tzachanis, James D. Levine, Robin Joyce, Edie Weller, Federico Campigotto, Heidi Mills, Poorvi Somaiya, Bimalangshu R. Dey, Tami Katz, Nikhil C. Munshi, Lynne Uhl, Baldev Vasir, Irit Avivi, Jacalyn Rosenblatt
Purpose: A multiple myeloma vaccine has been developed whereby patient-derived tumor cells are fused with autologous dendritic cells, creating a hybridoma that stimulates a broad antitumor response. We report on the results of a phase II trial in whi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::008e112b659829c9a6b5df166a140425
https://doi.org/10.1158/1078-0432.c.6522116
https://doi.org/10.1158/1078-0432.c.6522116
Autor:
David Avigan, Donald Kufe, Kenneth Anderson, Jacob Rowe, Viki Held, Lina Bisharat, Yan Emily Yuan, Vassiliki Boussiotis, Noopur Raje, Jacob Laubach, Paul Richardson, Dimitrios Tzachanis, James D. Levine, Robin Joyce, Edie Weller, Federico Campigotto, Heidi Mills, Poorvi Somaiya, Bimalangshu R. Dey, Tami Katz, Nikhil C. Munshi, Lynne Uhl, Baldev Vasir, Irit Avivi, Jacalyn Rosenblatt
PDF file - 522K, Percentage of CD8+T cells recognizing MUC1 tetramer in HLA 2.1+ patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04bf3b43e4e929fad1e7ca4d48bfe971
https://doi.org/10.1158/1078-0432.22451159.v1
https://doi.org/10.1158/1078-0432.22451159.v1
Autor:
Matthew S. Karafin, Robert A. DeSimone, James Dvorak, Ryan A. Metcalf, Monica B. Pagano, Yara A. Park, Joseph Schwartz, Rhona J. Souers, Zbigniew M. Szczepiorkowski, Lynne Uhl, Glenn Ramsey
Publikováno v:
Archives of Pathology & Laboratory Medicine.
Context.— Substantial variability between different antibody titration methods has been identified since the development and introduction of the uniform procedure in 2008. Objective.— To determine whether more recent methods or techniques decreas
Autor:
Jeffrey L. Carson, Maria Mori Brooks, Bernard R. Chaitman, John H. Alexander, Shaun G. Goodman, Marnie Bertolet, J. Dawn Abbott, Howard A. Cooper, Sunil V. Rao, Darrell J. Triulzi, Dean A. Fergusson, William J. Kostis, Helaine Noveck, Tabassome Simon, Philippe Gabriel Steg, Andrew P. DeFilippis, Andrew M. Goldsweig, Renato D. Lopes, Harvey White, Caroline Alsweiler, Erin Morton, Paul C. Hébert, Shahab Ghafghazi, Frances Wood, Mark Menegus, Barry Uretsky, Srikanth Vallurupalli, Gregory Maniatis, Luis Gruberg, Robert Roswell, Joseph Rossi, Farhad Abtahian, Meechai Tessalee, Gregory Barsness, Herbert Aronow, Kodangudi Ramanathan, Mark Schmidhofer, Friederike Keating, Michael Carson, Michael Kontos, Mansoor Qureshi, Stacey Clegg, Warren Laskey, Tamar Polonsky, Rajesh Gupta, Mujeeb Abdul Sheikh, Lynne Uhl, Paul Mullen, Arthur Bracey, William Matthai, Christopher Stowell, David Dudzinski, Gregary Marhefka, Perry Weinstock, William Lawson, Norma Keller, Eugene Yuriditsky, Michael Thomas, Alice Jacobs, Claudia Hochberg, Omar Siddiqi, Joshua Schulman-Marcus, Mikhail Torosoff, Michael Gitter, Xuming Dai, Jay Traverse, Eric McCamant, Jason Scott, Rajesh Swaminathan, Sunil Rao, Adam Salisbury, David Landers, Ganesh Raveendran, Ramin Ebrahimi, Richard Bach, Joseph Delehanty, Raj C. Shah, Sorin Brener, Jonathan Doroshow, Adriano Caixeta, Dalton Precoma, Frederico Toledo Campo Dall'Orto, Pedro Beraldo De Andrade, Marianna Dracoulakis, Lília Nigro Maia, Luiz Eduardo Fontelles Ritt, Alexandre Quadros, Dário Celestino Sobral Filho, Fernando De Martino, Thao Huynh, Greg Schnell, Manohara Senaratne, Vikas Tandon, John Neary, David Laflamme, Jean-Pierre Dery, Kevin Bainey, Richard Haichin, Payam Dehghani, Ata Ur Rehman Quraishi, Brian J. Potter, François Martin Carrier, Michael Goldfarb, Christopher Fordyce, Ying Tung Sia, Benoit Daneault, Mina Madan, Terry McPherson, John Ducas, Kunal Minhas, Neil Brass, Akshay Bagai, Simon Robinson, Vladimír Džavík, Razi Khan, Nicolas Michaud, Gabriel Steg, Gregory Ducrocq, Etienne Puymirat, Gilles Lemesle, Emile Ferrari, Benoit Lattuca, Johanne Silvain, Gérald Vanzetto, Laura Cetran, Thibault Lhermusier, Yves Cottin, Yann Rosamel, Denis Angoulvant, Jean Guillaume Dillinger, Christophe Thuaire, Batric Popovic, Eric Durand, Claire Bouleti, François Roubille, Laurent Delorme, Ian Crozier, Jocelyne Benatar, Samraj Nandra, Ian Ternouth, Nick Fisher, David Brieger, Graham Hillis
Publikováno v:
American heart journal.
Accumulating evidence from clinical trials suggests that a lower (restrictive) hemoglobin threshold (8% g/dL) for red blood cell (RBC) transfusion, compared with a higher (liberal) threshold (≥10 g/dL) is safe. However, in anemic patients with acut
Autor:
Matthew S. Karafin, Mary Berg, Yara A. Park, Lamont Thomas, Robert A. DeSimone, Joseph E. Schwartz, Nicole L Draper, Rhona J. Souers, Glenn Ramsey, Ryan A. Metcalf, Susan N. Rossmann, Jay Hudgins, Monica B. Pagano, Lynne Uhl, Joanne Becker
Publikováno v:
Archives of Pathology & Laboratory Medicine. 145:1499-1504
Context.— ABO mistransfusions are rare and potentially fatal events. Protocols are required by regulatory agencies to minimize this risk to patients, but how these are applied in the context of massive transfusion protocols (MTPs) is not specifical
Autor:
Lova Sun, Lynne Uhl, Pavan K. Bendapudi, Ang Li, Walter H. Dzik, Richard M. Kaufman, Christopher P. Stowell, Justine H. Ryu, Robert S. Makar, Meaghan E. Colling, Vivek A. Upadhyay
Publikováno v:
Transfusion. 60:841-846
BACKGROUND The introduction of therapeutic plasma exchange (TPE) dramatically decreased mortality in patients with immune thrombotic thrombocytopenic purpura (iTTP). However, there are few modern descriptions of residual causes of death from iTTP and
Publikováno v:
International Anesthesiology Clinics. 58:12-18
Autor:
David J. Chung, Nina Shah, Dina Stroopinsky, Juan (Maggie) Wu, Lina Bisharat, Natalie S. Callander, Brent Logan, Kenneth C. Anderson, Binod Dhakal, Steven M. Devine, Yvonne Efebera, Nancy Geller, Peiman Hematti, Leona A. Holmberg, Alan Howard, Bryon D Johnson, Hillard M. Lazarus, Ehsan Malek, Philip L. McCarthy, David H. McKenna, Adam Mendizabal, Nikhil C. Munshi, Lynn C. O’Donnell, Aaron P. Rapoport, Ajay Nooka, Jane S Reese, Robert J. Soiffer, Lynne Uhl, Giulia Cheloni, Dimitra Karagkouni, Ioannis Vlachos, Jim Young, Jacalyn Rosenblatt, Edmund K. Waller, Marcelo C Pasquini, David E. Avigan
Publikováno v:
Transplantation and Cellular Therapy. 28:S223-S224